Immuno-Oncology Equity Research Associate

LE001 Leerink Partners LLC; New York (NY); On-site; USD 135,000 - 170,000; Full time

Job summary

Leerink Partners LLC in New York is seeking an Equity Research Associate – Immuno-Oncology to work with senior analysts on cancer immunotherapy programs, spanning cell therapy to traditional modalities and covering multiple company sizes. You will collect primary data, build and maintain models, and develop investment ideas while monitoring regulatory, clinical, and market developments.

A PhD/MD or related Master’s and strong quantitative skills are required, with a focus on rigorous primary

Qualifications

• Advanced degree in a relevant scientific/quantitative field (PhD/MD or related Master’s).
• Strong quantitative and analytical skills; hands-on experience with statistical or simulation-based analysis.

Responsibilities

• Collect and analyze primary data and expert opinion related to cancer immunotherapy.
• Maintain and analyze a database of ongoing cancer immunotherapy trials, including revenue and commercial simulations.
• Build, update, and maintain financial models.
• Formulate investment recommendations based on fundamental analysis, valuation, and risk assessment of individual companies.
• Write research reports and notes on companies, immunotherapy mechanisms and modalities, and specific cancer settings for institutional clients and corporate audiences.
• Stay current on relevant company, market, scientific, clinical, and regulatory developments.
• Support senior equity research professionals at medical and scientific conferences, including preparation, attendance, and post-conference analysis.
• Respond to inquiries from firm personnel and clients.

Skills

Advanced degree

Financial modeling

Excel skills

Statistical/simulation analysis

Communication skills

Biotech/pharma knowledge

AI tools in research

Education

PhD/MD or related Master’s

Tools

Excel

Access

Job description

Leerink Partners LLC in New York is seeking an Equity Research Associate – Immuno-Oncology to work with senior analysts on cancer immunotherapy programs, spanning cell therapy to traditional modalities and covering multiple company sizes. You will collect primary data, build and maintain models, and develop investment ideas while monitoring regulatory, clinical, and market developments.

A PhD/MD or related Master’s and strong quantitative skills are required, with a focus on rigorous primary